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Case report 1
A 39-year-old female with refractory AML in blast crisis 
and an absolute neutrophil count under 500 cells/
microliter presented with nasal drainage that was unre-
sponsive to antibiotic treatment. A CT scan showed a new 
right-nasal-cavity mucosal edema with subtle orofacial soft-
tissue infiltration (Fig. 1A), compared to CT performed two 
weeks earlier for unrelated facial trauma (Fig. 1B). There 
was no paranasal sinus opacification or evidence of  bone 
erosion. MRI performed the following day demonstrated 
further orofacial soft-tissue infiltration and nonenhancing 
right-nasal-cavity mucosa (Figs. 1C, D). Extensive drainage 
and crusting at the right nares prevented nasal endoscopy, 
but cultures of  the drainage grew Mucormycosis species.
Antifungal therapy was initiated, and surgical debride-
ment of  the necrotic nasal mucosa, right inferior turbinate, 
and nasal septum was performed. Given the patient’s re-
fractory AML and blast crisis, the patient was placed on 
palliative care and died from sepsis 7 days later.
Case report 2
A 15-year-old male with newly diagnosed hemophago-
cytic lymphohistiocytosis and an absolute neutrophil count 
under 500 cells/microliter developed fever and facial swel-
ling ten days following induction chemotherapy. CT and 
MRI showed minimal orofacial soft-tissue infiltration with-
out paranasal sinus, nasal cavity, or bone erosion (Figs 2A, 
B). Nasal endoscopy demonstrated healthy mucosa without 
sinonasal disease. Given these findings, the facial pain and 
swelling were ascribed to cellulitis, and the patient was 
placed on antibiotics. 
Over the next four days, the patient experienced progres-
sive facial swelling and pain and developed a right cheek 
eschar. Repeated nasal endoscopy demonstrated necrotic 
mucosa involving the nasal septum, floor, and side walls. 
Biopsies revealed invasive Mucormycosis species. Repeated 
MRI confirmed these findings with worsening orofacial 
soft-tissue infiltration and new maxillary sinus mucosal 
edema (Figs. 2C, D).
Given the poor prognosis from the hemophagocytic lym-
phohistiocytosis, surgical debridement was deferred and 
medical management was optimized. Chemotherapy was 
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held, and multiple antifungal agents, granulocyte-colony 
stimulating factor, and granulocyte infusions were adminis-
tered. The patient remained neutropenic and died from 
sepsis 10 days later.
Discussion
Orofacial soft-tissue infiltration in an immunocompro-
mised patient is an independent radiologic sign of  invasive 
facial fungal infections. The normal orofacial soft tissues are 
composed of  well-defined facial muscles separated by intact 
planes of  fat. This relationship is maintained in nearly all 
normal patients, even in the presence of  inflammatory si-
nus disease (1). In cases of  invasive facial fungal infections, 
these planes are disrupted when fungal species disseminate 
intravascularly, causing an infectious vasculitis with conse-
quent soft-tissue hemorrhage, thrombosis, and 
infarction (2). 
Secondary invasive facial fungal infections are an exten-
sion of  acute fulminant invasive fungal sinusitis and there-
fore share similar imaging features. Nasal-cavity opacifica-
tion has been described as the earliest sign of  invasive fun-
gal disease; however, this finding can be extremely subtle 
and can also be seen with benign inflammatory sinusitis (3, 
4). The presence of  nonenhancing mucosa adds specificity, 
which pathologically correlates with necrotic mucosa (5, 6). 
From the nasal cavity, disease spreads to the maxillary sinus  
and orofacial soft tissues. Bone erosion and intraorbital and 
intracranial invasion are late findings indicative of  ad-
vanced disease (7, 8).
Primary invasive facial fungal infections begin in the oro-
facial soft tissues and are not expected to have sinonasal 
involvement until later in their course. The pathogenesis of 
primary invasive facial fungal infections is likely similar to 
primary disease outside of  the head and neck and has been 
well described in immunocompromised patients, particu-
larly pediatric patients with hematologic malignancies (9). 
Iatrogenic trauma to the protective dermal layers by adhe-
sives and catheters allows fungus access to the subcutane-
ous tissues, allowing for dissemination (10, 11). In our case 
of  primary disease, direct inoculation may have occurred 
from the adhesives used to secure a feeding tube. The ab-
sence of  clinical or imaging findings of  sinonasal disease 
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Figure 2. 15-year-old male with hemophagocytic lymphohistiocytosis developed neutropenic fever and facial swelling following 
induction chemotherapy. (A) Noncontrast sinus CT and (B) T1-weighted MRI demonstrate right orofacial soft-tissue infiltration 
without sinonasal disease (arrows). T2-weighted (C) and T1-weighted (D) MRI on Day 4 demonstrate significant disease pro-
gression, with involvement of the nasal cavity and maxillary sinuses.
Figure 1. 39-year-old female with refractory AML in blast crisis presented with nasal drainage unresponsive to antibiotic treat-
ment. (A) Noncontrast sinus CT demonstrates an opacified right-nasal-cavity and subtle right-orofacial soft-tissue infiltration 
(arrow) with adjacent nasal-cavity mucosal edema. (B) Noncontrast facial CT performed for trauma two weeks earlier demon-
strates a hematoma (arrow), but normal orofacial soft tissue. (C) T2-weighted and (D) T1-weighted post-gadolinium, fat-
saturated MRI performed on Day 2 demonstrates progression, with worsening orofacial soft-tissue infiltration and nonenhanc-
ing nasal cavity mucosa (arrows). 
highlights the need to raise the possibility of  an invasive 
fungal infection even when only orofacial soft-tissue infiltra-
tion is seen on imaging. 
Orofacial soft-tissue infiltration can occur in conditions 
aside from invasive fungal infections. Trauma, dental dis-
ease, bacterial cellulitis, and (more recently) dermal fillers 
can mimic the imaging appearance of  invasive facial fungal 
infections. Dermal fillers are unique in that they are fre-
quently used to treat retroviral lipodystrophy in HIV pa-
tients, a subset at high risk for invasive fungal disease (12). 
Hyaluronic acid is most commonly used, but other agents 
include collagen, silicone, and polytetrafluoroethylene. The 
CT and MRI appearance of  these agents vary, but a tran-
sient inflammatory reaction is common, with occasional 
occurrences of  a severe chronic inflammatory response 
with diffuse swelling and enhancement of  the orofacial soft 
tissues (13, 14). Knowledge of  the appropriate clinical his-
tory is necessary to avoid this potential pitfall.
The treatment of  invasive facial fungal infections is simi-
lar to that for other invasive fungal diseases and is based on 
a three-pronged approach: antifungal therapy, surgical 
debridement, and immune recovery. Antifungal therapy 
and surgical debridement limit spread and disease burden, 
but ultimately immune recovery is the best predictor of  
survival (5). Early recognition of  the imaging signs of  pri-
mary and secondary invasive facial fungal infections allows 
for appropriate diagnostic testing and treatment, thereby 
offering the patient the best chances for recovery.
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